Sema4 is transforming healthcare by using artificial intelligence to enable the delivery of precision medicine as the standard of care.
Our unique analytics platform, Centrellis, enables us to transform standard of care insights by reconstructing longitudinal patient journeys, derive population health insights, and deliver AI-powered disease models.
Sema4’s accomplished research team includes world leaders in data science, machine learning, network modeling, and genomics. We’ve published more than 180 peer-reviewed papers and are committed to providing science-driven solutions to the most pressing medical needs.
Our Sema4 Elements™ portfolio of information-driven genomic solutions, digital tools, and services enables providers to treat patients holistically during their reproductive and generational health journey, from preconception planning to hereditary cancer testing.
Our family of precision oncology products and services, Sema4 Signal®, provides data-driven care solutions with advanced analytics, digital tools, and exome-based somatic and hereditary cancer genomic tests.
Sema4 offers an extensive portfolio of health information solutions, including pre-clinical and clinical trial support, analytics for actionable insights, and advanced sequencing services, to drive informed decision-making across the drug discovery, development, and commercialization lifecycle.
